4//SEC Filing
MCCARTHY GLORIA M 4
Accession 0001156039-23-000037
CIK 0001156039other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 4:20 PM ET
Size
14.7 KB
Accession
0001156039-23-000037
Insider Transaction Report
Form 4
MCCARTHY GLORIA M
EVP, Office of the CEO
Transactions
- Sale
Common Stock
2023-03-24$446.06/sh−3,625$1,616,968→ 51,435 total - Sale
Common Stock
2023-03-24$440.78/sh−600$264,468→ 65,933 total - Sale
Common Stock
2023-03-24$442.02/sh−500$221,010→ 65,433 total - Sale
Common Stock
2023-03-24$443.27/sh−1,800$797,886→ 63,633 total - Sale
Common Stock
2023-03-24$444.33/sh−3,000$1,332,990→ 60,633 total - Sale
Common Stock
2023-03-24$445.30/sh−5,573$2,481,657→ 55,060 total
Footnotes (7)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2023.
- [F2]This transaction was executed in multiple trades at prices ranging from $440.36 to $441.05. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $441.60 to $442.55. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $442.71 to $443.67. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $443.73 to $444.72. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F6]This transaction was executed in multiple trades at prices ranging from $444.73 to $445.72. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F7]This transaction was executed in multiple trades at prices ranging from $445.73 to $446.42. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Elevance Health, Inc.
CIK 0001156039
Entity typeother
Related Parties
1- filerCIK 0001203671
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 4:20 PM ET
- Size
- 14.7 KB